1. Home
  2. RDY vs KYN Comparison

RDY vs KYN Comparison

Compare RDY & KYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
    SELLHOLDBUYas of 11 hours ago
  • KYN
    SELLHOLDBUYas of 11 hours ago
  • Stock Information
  • Founded
  • RDY 1984
  • KYN 2004
  • Country
  • RDY India
  • KYN United States
  • Employees
  • RDY N/A
  • KYN N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • KYN Finance/Investors Services
  • Sector
  • RDY Health Care
  • KYN Finance
  • Exchange
  • RDY Nasdaq
  • KYN Nasdaq
  • Market Cap
  • RDY 2.1B
  • KYN 2.2B
  • IPO Year
  • RDY N/A
  • KYN N/A
  • Fundamental
  • Price
  • RDY $12.46
  • KYN $10.52
  • Analyst Decision
  • RDY Buy
  • KYN
  • Analyst Count
  • RDY 1
  • KYN 0
  • Target Price
  • RDY $17.00
  • KYN N/A
  • AVG Volume (30 Days)
  • RDY 2.3M
  • KYN 561.5K
  • Earning Date
  • RDY 05-06-2025
  • KYN 01-01-0001
  • Dividend Yield
  • RDY 3.77%
  • KYN 8.99%
  • EPS Growth
  • RDY 2.68
  • KYN N/A
  • EPS
  • RDY 0.75
  • KYN 0.71
  • Revenue
  • RDY $3,637,607,642.00
  • KYN N/A
  • Revenue This Year
  • RDY $17.23
  • KYN N/A
  • Revenue Next Year
  • RDY $9.19
  • KYN N/A
  • P/E Ratio
  • RDY $16.79
  • KYN $13.79
  • Revenue Growth
  • RDY 14.74
  • KYN N/A
  • 52 Week Low
  • RDY $12.26
  • KYN $7.84
  • 52 Week High
  • RDY $16.89
  • KYN $9.88
  • Technical
  • Relative Strength Index (RSI)
  • RDY 34.67
  • KYN 19.73
  • Support Level
  • RDY $12.28
  • KYN $9.82
  • Resistance Level
  • RDY $12.88
  • KYN $11.50
  • Average True Range (ATR)
  • RDY 0.23
  • KYN 0.39
  • MACD
  • RDY -0.08
  • KYN -0.27
  • Stochastic Oscillator
  • RDY 11.46
  • KYN 21.72

Stock Price Comparison Chart: RDY vs KYN

RDY
KYN
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01020304050607080RDY VS KYN

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use